H2

H2 P/B

The P/B (Price-to-Book Ratio) of H2 (7851.TWO) as of Nov 5, 2026 is -2.67. In the previous year, P/B (Price-to-Book Ratio) was -3.69 — a change of -27.63% (higher).

P/B

-2.67

YoY

-27.63%

Last updated:

P/B (Price-to-Book Ratio) of H2 is 2024 -2.67 . P/B (Price-to-Book Ratio) of H2 was 2023 -3.69 . It decreases by -27.63% higher compared to the previous year.

The H2 P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2023
-3.69 TWD
Jan 1, 2024
-2.67 TWD
The H2 P/B history
YEARP/BYoY
-2.67-27.63%
-3.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

H2 Stock analysis

What does H2 do? H2 Inc generates revenue through its Health2Sync App, which offers a premium membership providing deeper analysis of health readings and educational content. The Patient Management Platform is sold to healthcare providers for patient prioritization and data-driven insights. Data Syncing supports integration with blood glucose meters, blood pressure monitors, weight scales, insulin pens, and CGMs, enabling seamless data import from various devices. The company serves healthcare providers, patients managing chronic conditions, and partners offering care services. Health2Sync App targets patients seeking daily management of chronic diseases through mobile and digital therapeutics, with features like tracking trends and receiving reminders. Premium members access advanced analytics and educational resources. The Patient Management Platform caters to healthcare organizations needing instant platform deployment and improved communication tools. Data Syncing facilitates connectivity with supported devices including CGM and insulin pen apps, enhancing user experience across the ecosystem. The company monetizes through subscription-based premium memberships for individual users and licensing fees for the Patient Management Platform to healthcare institutions. Data Syncing is integrated into the core product suite, driving adoption through device compatibility. Healthcare providers, chronic disease patients, and care partners form the primary customer segments purchasing these solutions. H2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H2 stock

P/B (Price-to-Book Ratio) of H2 is -2.67 in 2024.

P/B (Price-to-Book Ratio) of H2 changed from -3.69 to -2.67, representing a -27.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) H2 since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s H2 with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — H2

All Key Metrics — H2